- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Soraprazan
| EU orphan designation number: | EU/3/13/1208
|
| Active ingredient: | Soraprazan |
| Indication: | Treatment of Stargardt’s disease |
| Sponsor: | Katairo GmbH
Lederstrasse 21, 72127 Kusterdingen, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 15/11/2013 | Orphan designation | EMA/OD/124/13 | (2013)8055 of 13/11/2013 |


